Table 4

Overall survival
Factors Overall survival
Number Mean (years) 95% CI χ2 P
All patients 136 9.5 8.1-11.0
Sex 2.053 0.152
 Female 54 9.9 8.5-11.3
 Male 82 8.7 6.7-10.6
Age 0.259 0.611
 ≤50 60 9.9 8.0-11.8
 >50 76 7.8 5.9-9.6
Site 2.385 0.123
 Gastrointestinal tract 77 6.7 5.4-8.0
 Pancreas 46 11.1 9.3-12.9
Functional status 6.691 0.006
 Functional 22 NR NC
 Nonfunctional 114 7.7 6.1-9.2
Tumor grading 9.087 0.011
 G1 63 10.8 8.7-12.9
 G2 25 3.5 2.6-4.3
 G3 41 4.1 2.8-5.4
Tumor type 6.634 0.010
 NET 88 10.1 8.1-12.1
 NEC + MANEC 41 4.1 2.8-5.4
Distant metastasis 23.773 0.000
 Yes 44 5.0 2.7-7.3
 No 92 11.0 9.2-12.8

CI, confidence interval; NR, not reached; NC, not computable; NET, neuroendocrine tumor; NEC, neuroendocrine carcinoma; MANEC, mixed adenoendocrine carcinoma.

Wang et al.

Wang et al. BMC Endocrine Disorders 2012 12:30   doi:10.1186/1472-6823-12-30

Open Data